Grape King Bio Ltd. · TWSE:1707
Grape King Bio — Investor Presentation (March 2025)
36 slides from Grape King Bio's investor presentation, March 2025
Slide 1: Investor Presentation March 2025
1707 TT I N VE S T O R P RE S EN T A TI O N MARCH 2025
Slide 2: Disclaimer
Disclaimer • This document is provided by Grape King Bio. (the "Company"). Except for the numbers and information included in the Company's financial statements, the information contained in this document has not been audited or reviewed by any accountant or independent expert. The Company makes no
Slide 3: Grape King Bio: A New Chapter Built on Scientific Depth, Market Leadership & Global Expansion
Grape King Bio: A New Chapter Built on Scientific Depth, Market Leadership & Global Expansion Grape King Bio is entering a new era of scalable, innovation-led growth. Backed by decades of R&D, the company holds over 4,000 proprietary strains and 1,000+ formulations — making it one of the most scient
Slide 4: Company Introduction
Company Introduction
Slide 5: Mission: advancing well-being through biotechnology
Wellness today isn’t just about staying healthy — it’s about feeling your best, inside and out, mind and body That’s why we’re on a mission to advance well-being through biotechnology—helping people live healthier, fuller lives 5
Slide 6: Proprietary strains and advanced fermentation
By combining proprietary strains and advanced fermentation, we create easy-to-consume wellness solutions—making better health simple, seamless, and accessible 6
Slide 7: Direct selling, retail partnerships and ODM collaborations
Through direct selling, retail partnerships, and ODM collaborations, we’re expanding globally—bringing better health to more people, places, and channels than ever before 7
Slide 8: 2025 and beyond marks a new chapter for Grape King Bio
2025 and beyond marks a new chapter for Grape King Bio. Taiwan’s Science-Based Entering the Health Energizing Growth Product Growth and Energy Drink Pioneer Supplement Market Through Brand Renewal Global Expansion 1969 ~ 1990 1991 ~ 2013 2014 ~ 2024 2025 ~ Onward From pharmaceutical beginnings, In 1
Slide 9: Proven growth, poised for more
Proven growth, poised for more Consolidated Revenue (NT$bn) 12.0 10.0 8.0 6.0 4.0 2.0 0.0 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 2022 2024 9
Slide 10: Bridging the Health Gap: Serving High-Growth & Unmet Wellness Needs
Bridging the Health Gap: Serving High-Growth & Unmet Wellness Needs IMMUNE & GUT & ORGAN MIND & EMOTIONAL BEAUTY & PRO- METABOLIC HEALTH HEALTH WELLNESS AGING Immune Vitality Gut Health Digestive Care Focus & Brain Skin Health Brightening Regulation Health Weight Blood Sugar Liver Health Kidney Heal
Slide 11: Health Solutions for Everyone: From Daily Wellness to Pharmaceuticals
Health Solutions for (Our Best Sellers) 1 Fast Moving Consumer Goods (Nourish me) Everyone: From Daily KOMBUCHA NO.1 IN TAIWAN ENERGY DRINKS NO.3 IN TAIWAN Wellness to >50% MARKET SHARE 8% MARKET SHARE Pharmaceuticals Functional RTD Tea Energy Drinks Combest Kombucha PowerBomb 2 Functional/Health Su
Slide 12: Unmatched Innovation & Scale: Grape King's Competitive Moats
Unmatched Innovation & Scale: Grape King’s Competitive Moats Grape King Pinzhen 270 + 225 + 194 Factory and HQ Asia’s Largest Fermentation 587 tons >4000 Scientific Capacity: Leadership & Credibility Custom Formulation >1000 Unmatched Microbial Innovation Expertise >10 Manufacturing & Delivery Advan
Slide 13: Comprehensive Market Coverage: Reaching Consumer Across All Channels
Comprehensive Market Coverage: Reaching Consumer Across All Grape King’s Channels Distribution Channels Online Retail Grape King Own OEM/ODM Brands Pro-Partner Global Offline Markets Retail Greater Taiwan China Malaysia 13
Slide 14: Our Strategies
Our Strategies
Slide 15: Driving Sustainable Growth: Our 4-Pillar Strategy for Market Leadership
Driving Sustainable Growth: Our 4-Pillar Strategy for Market Leadership Scaling Star Products Expanding Pro-Partner Expanding Global ODM Strengthening China & Innovation & New Markets Leadership Business & Retail Execution Launching science-backed, Strengthening direct sales in Scaling ODM through A
Slide 16: GKM3 'Sliim' Probiotics: A Star Product Driving Growth
GKM3 ‘Sliim’ Probiotics: A Star Product Driving Growth Supports Healthy Body Fat Levels Vegetarian Friendly Enhance Metabolism Scientifically Backed, National Health Certification, Patented GKM3® Probiotic Strain: Exclusively developed to support body fat reduction and metabolic health Eat few fruit
Slide 17: Fueling Growth Through Continuous Product Innovation & Expansion
Fueling Growth Through Continuous Product Innovation & Expansion AUG, 2023 SEP, 2023 MAR, 2024 Kang Er Dong Shu Wei Guo Lutein Jelly Pack (Energy Probiotics) (Stress Relief Boosts stamina, Gummies) endurance, and post- workout recovery Cactus, olive leaf, FloraGLO lutein, bilberry, and Lion’s Mane a
Slide 18: Beyond Supplement: Scaling Pro-Partner with Skincare Innovation
Beyond Supplement: Scaling Pro-Partner with Skincare Innovation Why Skincare Is the Logical Move? • With 80% of Pro-Partner members being females, skincare is a natural next step for product expansion. • Separate spending habits: Beauty & skincare spending do not compete with supplements. • Global s
Slide 19: Pro-Partner Goes Global: Scaling Direct Sales in Malaysia
Pro-Partner Goes Global: Scaling Direct Sales in Malaysia Laying the Foundation Execution & Growth 1H25 2H25 • Product Certification – 20 • Government Licensing – SKUs planned, 5 submitted Obtain business permit & for MAL certification product registration • Local Team Setup – • Leader Recruitment –
Slide 20: Scaling Wallet Share: How We Grew with a Key ODM Customer
01 Entry & Initial Partnership • Customer visits Grape King Taiwan and conducts a facility audit (2018-2019). (2018-2019) • Initial discussions on ODM partnership begin. First Product 02 Launch & • First probiotic product launched in Taiwan (2020), driving 4.5x YoY revenue growth. Scaling Wallet Mar
Slide 21: ODM Without Borders: Scaling Partnerships in Key Global Markets
ODM Without Borders: Scaling Partnerships in Key Global Markets • Manufacturing for a top • R&D collaboration with • Partnering with a brain probiotic brand, two legacy brands (40+ health company to supply distributed across years history), with strong Lion’s Mane mushroom & major retail channels &
Slide 22: China Strategy: Strengthening Market Position Through Innovation & Expansion
China Strategy: Strengthening Market Position Through Innovation & Expansion Market Context & Core Growth Drivers / Consumer Shifts Execution • Post pandemic shift – • Leveraging proprietary raw Consumers prioritizing materials for unique, self- affordable function FMCG branded and OEM/ODM over prem
Slide 23: Inorganic Growth: Supporting Global Reach & Capabilities Through Selective M&A
Inorganic Growth: Supporting Global Reach & Capabilities Through Selective M&A Strategic Guiding Rationale Principles • Expand local supply • Opportunities that align chain capabilities in with our health & key markets (e.g., wellness focus. Malaysia). • Strategic fit in supply • Get closer to OEM/O
Slide 24: Advancing Sustainability: ESG Milestones & Global Acknowledgment
Advancing Sustainability: ESG Milestones & Global Acknowledgment 2024 2024 2024 MSCI ESG Rating S&P Global ESG Scores Sustainalytics ESG Risk Rating Scores ARating Scores 56 /100 Scores 21.3 /100 (CCC-AAA, Best score: AAA) (0-100, Best score: 100) (0-100, Best score: 0) Ranked 3rd in Taiwan 6 Ranked
Slide 25: Building a Sustainable Future: 2024 ESG Results & Highlights
Building a Sustainable Future: 2024 ESG Results & Highlights 2024 2024 2024 Renewable Energy Water Recycle Circular Economy 5.5% 66,087 tons 258 tons Electricity saving rate reached Amount of food sludge used 5.5%, exceeding the 5% target Total volume of recycled water as auxiliary fuel for and impr
Slide 26: Financials
Financials
Slide 27: Revenue and Operating Profit Breakdown
Revenue and Operating Profit Breakdown 2024 Revenue 2024 Operating Profit 8% 4% 5% 12% NT$ NT$ 11.16bn 2.50bn 79% 91% Retail Distribution Direct Sales OEM/ODM 27
Slide 28: BU Revenue and Net Profit Breakdown
BU Revenue and Net Profit Breakdown 2024 Revenue 2024 Net Profit 10% 11% 1% 24% NT$ NT$ 11.16bn 1.45bn 76% 79% Grape King Taiwan Pro-Partner Grape King Shanghai 28
Slide 29: 4Q24 Income Statement
4Q24 Income Statement 4Q24 4Q23 YoY (%) Revenue 3,155 3,200 (1.4) Gross Profit 2,473 2,552 (3.1) Gross Margin (%) 78.4 79.7 -1.4 ppts Operating Expenses (1,708) (1,730) (1.3) Operating Profit 764 822 (7.0) Operating Margin (%) 24.2 25.7 -1.5 ppts Non Operating Income/(Loss) 56 40 39.9 Net Income 672
Slide 30: 2024 Income Statement
2024 Income Statement 2024 2023 YoY (%) Revenue 11,160 10,635 4.9 Gross Profit 8,658 8,536 1.4 Gross Margin (%) 77.6 80.3 +2.7 ppts Operating Expenses (6,158) (6,037) 2.0 Operating Profit 2,500 2,497 0.1 Operating Margin (%) 22.4 23.5 +1.1 ppts Non Operating Income/(Loss) 173 164 5.8 Net Income 2,17
Slide 31: 4Q24 Balance Sheet
4Q24 Balance Sheet 2024-12-31 2023-12-31 Amount % Amount % Cash and Cash Equivalents 4,343 28.3 4,819 31.1 AR & NR 305 2.0 291 1.9 Inventories 754 4.9 688 4.4 PP&E 7,699 50.2 7,539 48.6 Total Assets 15,324 100 15,512 100 Current Liabilities 3,323 21.7 3,647 23.5 Interest-bearing Liabilities 210 1.4
Slide 32: 4Q24 Cashflow
4Q24 Cashflow 4Q24 4Q23 Beginning Balance 4,819 4,673 Operating Cash Flow 1,876 2,519 Capital Expenditures -627 -587 Investments and Others -35 -68 Financing Cash Flow -1,717 -1,709 Effects of Exchange Rate Changes on the Balance of Cash and Cash Equivalents 27 -10 Held in Foreign Currencies Ending
Slide 33: Income Statement Summary
Income Statement Summary NT$mn 2017 2018 2019 2020 2021 2022 2023 2024 Revenue 9,388 9,183 9,239 9,168 9,798 10,391 10,635 11,160 Gross Profit 7,865 7,329 7,566 7,537 7,856 8,482 8,536 8,658 Operating Expenses (5,610) (4,979) (5,231) (5,232) (5,544) (5,929) (6,037) (6,158) Operating Profit 2,254 2,3
Slide 34: Balance Sheet Summary
Balance Sheet Summary NT$mn 2017 2018 2019 2020 2021 2022 2023 2024 Total Assets 9,892 10,648 11,359 13,104 14,061 15,053 15,512 15,324 Cash and Cash Equivalents 1,920 2,050 2,146 2,927 3,635 4,673 4,819 4,343 AR & NR 160 171 202 202 301 270 291 305 Inventories 492 563 546 689 719 688 688 754 PP&E 6
Slide 35: Dividend Payout and Capex
Dividend Payout and Capex 6.68 6.90 6.90 6.90 6.40 6.50 6.50 6.40 6.10 5.60 5.30 5.00 3.70 3.00 2.50 2.00 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 P AY OU T R AT I O ( % ) 69 76 83 79 78 73 69 65 67 68 67 69 69 70 70 71 D I VI D END YI EL D ( % ) 8.9 5.5 6.1 6.
Slide 36: Thank You
Thank You Get in touch? Grape King Investor Relations Contact Mr. Duncan Aitken Global Business Director Group Chief Sustainability Officer Email: duncan.aitken@grapeking.com.tw Phone: +886 (3) 457 2121 #1802